About the session
Gene therapy has emerged as one of the most challenging topics for employers and their benefits programs. With costs that can reach hundreds of thousands of dollars for one-time treatments, these potentially life-changing therapies can be used to prevent, treat, or even cure certain diseases. Given the steady increase in the availability of gene therapies, it is essential for plan sponsors to understand the key clinical, operational, and financial implications of gene therapy to optimize access and value for both their members and organization.
Weren’t able to join the webinar? Be sure to watch the recording or read the recap.
In this session, originally aired on August 3rd, 2021, Truveris expert, Joe Thomas, PharmD, MPBA, took a deep dive into the current trends in the cell and gene therapy market. The webinar extends beyond defining gene therapy and itemizing the associated costs. Rather, it focuses on identifying appropriate use cases for these groundbreaking treatment options for patients, and outlining payer strategies for anticipating and managing these cases.
Original air time and date
Tue, Aug 3, 2021 · 12:00 PM EDT
Agenda of session
- Best practices for navigating the gene therapy journey across employee benefits broker, plan sponsor, and member stakeholder groups
- The value of gene therapy and its role in the advancement of care
- Current and future pipeline approvals and availability
About the presenter: Joe Thomas, PharmD, MPBA
Joe has spent nearly 15 years as a clinical expert, unveiling new trends and insights in specialty care.
Prior to joining Truveris as a Client Services Director, Joe spent 4 years with CVS Health as a Clinical Advisor within the PBM Coalition Business Unit. Joe has also served as a Clinical Pharmacist for Accredo, Walgreens Home Infusion Services, and Walgreens Specialty Pharmacy.
Joe is an adjunct professor at the University of Pittsburgh, where he teaches managed care. He is a licensed pharmacist in two states and also a certified specialty pharmacist and certified pharmacy benefit specialist.
Joe earned his Doctor of Pharmacy in 2010 from the Mylan School of Pharmacy at Duquesne University in Pittsburgh, PA. In 2017, he earned his Master of Pharmacy Business Administration from the University of Pittsburgh.
Watch the webinar on-demand now